About 94,200 results
Press Room - Sanofi US News
Sanofi moves on J&J in first-line myeloma with FDA nod
Press Release: Sarclisa approved in the US as the first anti-CD38 ...
ASCO: Sarclisa is first anti-CD38 to significantly improve ... - Sanofi
Press Room - Sanofi US News
Press Release: Sarclisa accepted for FDA priority review for ... - Sanofi
Sanofi Says FDA Approves Sarclisa for Treatment of Blood Cancer ...
FDA Approves Isatuximab With VRd as First-Line Option for …
Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of ... - Sanofi
Sanofi wins US approval for multiple myeloma drug in newly
- Some results have been removed